▶ Manufacturer : Ilhwa Co., Ltd.
▶ Sold by : Ilhwa Co., Ltd.
▶ Insurance code : 640902891
▶ Storage : Airtight container, store at room temperature (2 to 25℃)
White or near-white opaque suspension in spray container
50㎍ Mometasone Furoate per 1 Dose (anhydrous)
1. Allergic rhinitis
Each press of the spray cap releases approximately 100mg mometasone furoate solution, containing 0.05mg (anhydrous) mometasonfuroate. For uniform spraying, use after test spraying 10 times. If the spray has not been used for 14 days or longer, test spray 2 times before next use.
1) Adults (including elderly patients) and children 12 years and above:
Spray twice into each nasal cavity once a day (total daily dose 0.2mg). If symptoms are alleviated, reduce dose to maintenance dose of 1 spray per nasal cavity as a maintenance dose (total daily dose 0.2mg).
If symptoms are not alleviated, dose may be increased to 4 sprays once a day in each nose cavity (total daily dose 0.4mg). Lowering dose is recommended if symptoms are alleviated. Use regularly for best treatment benefits.
2) Children 2 to 11
Spray once into each nasal cavity once a day (total daily dose 0.1mg)2. Nasal polyps
Spray twice into each nasal cavity once a day (total daily dose 0.2mg). If symptoms are not alleviated after 5 to 6 weeks, increase dose and spray twice into each nasal cavity twice a day (total daily dose 0.4mg). Recommend reducing dose if symptoms are alleviated.
If symptoms are not alleviated even after 5 to 6 weeks of twice daily administration, consider other treatment.
No studies on using this drug for 4 months or longer for treatment of nasal polyps.
3. Acute sinusitis
Spray twice into each nasal cavity twice a day (total daily dose 0.4mg).
1. Adults and children over 2 : Seasonal allergic rhinitis and persistent rhinitis. Preventive therapy for patients previously having moderately severe to severe seasonal allergic rhinitis symptoms may begin 2 to 4 weeks prior to expected date of pollen period (expected date of allergen exposure).
2. Adults 18 years and older : Nasal polyps
3. Adults and youth over 12 : Acute sinusitis without severe bacterial infection
White or near-white opaque suspension in spray container
50㎍ Mometasone Furoate per 1 Dose (anhydrous)
1. Allergic rhinitis
Each press of the spray cap releases approximately 100mg mometasone furoate solution, containing 0.05mg (anhydrous) mometasonfuroate. For uniform spraying, use after test spraying 10 times. If the spray has not been used for 14 days or longer, test spray 2 times before next use.
1) Adults (including elderly patients) and children 12 years and above:
Spray twice into each nasal cavity once a day (total daily dose 0.2mg). If symptoms are alleviated, reduce dose to maintenance dose of 1 spray per nasal cavity as a maintenance dose (total daily dose 0.2mg).
If symptoms are not alleviated, dose may be increased to 4 sprays once a day in each nose cavity (total daily dose 0.4mg). Lowering dose is recommended if symptoms are alleviated. Use regularly for best treatment benefits.
2) Children 2 to 11
Spray once into each nasal cavity once a day (total daily dose 0.1mg)2. Nasal polyps
Spray twice into each nasal cavity once a day (total daily dose 0.2mg). If symptoms are not alleviated after 5 to 6 weeks, increase dose and spray twice into each nasal cavity twice a day (total daily dose 0.4mg). Recommend reducing dose if symptoms are alleviated.
If symptoms are not alleviated even after 5 to 6 weeks of twice daily administration, consider other treatment.
No studies on using this drug for 4 months or longer for treatment of nasal polyps.
3. Acute sinusitis
Spray twice into each nasal cavity twice a day (total daily dose 0.4mg).
1. Adults and children over 2 : Seasonal allergic rhinitis and persistent rhinitis. Preventive therapy for patients previously having moderately severe to severe seasonal allergic rhinitis symptoms may begin 2 to 4 weeks prior to expected date of pollen period (expected date of allergen exposure).
2. Adults 18 years and older : Nasal polyps
3. Adults and youth over 12 : Acute sinusitis without severe bacterial infection
